Kura Oncology, Inc. (KURA) Balance Sheet
As of 2026-06-30 (10-Q), Kura Oncology, Inc. (KURA) reported total assets of $587.8M, total liabilities of $539.4M and shareholders' equity of $48.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $70.2M. Long-term debt: $5.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
KURAKura Oncology, Inc.Follow KURA — free
—
Price chart with a free account
- Market cap
- 854.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.0 | 0.0 | 1.1 | 15.4 | 9.7 | 11.4 | 16.1 | 26.1 | 325.5 | 90.7 | 51.8 | 37.3 | 224.5 | 149.1 | 70.2 | |
| Short-term investments | — | — | — | 70.3 | 58.1 | 81.7 | 162.9 | 210.8 | 307.8 | 427.3 | 386.2 | 386.6 | 502.9 | 518.1 | 448.8 | |
| Receivables | — | — | — | — | — | — | — | — | — | — | — | — | 2.1 | 8.8 | 9.4 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.4 | 2.5 | |
| Current assets | 0.0 | — | 1.2 | 86.9 | 68.8 | 94.6 | 181.2 | 239.6 | 637.3 | 522.3 | 446.4 | 432.5 | 744.8 | 708.7 | 559.4 | |
| Total assets | 0.0 | 0.0 | 1.4 | 87.3 | 69.8 | 95.9 | 182.4 | 242.0 | 647.2 | 534.1 | 456.3 | 448.9 | 760.2 | 738.4 | 587.8 | |
| Current liabilities | 0.1 | — | 3.0 | 5.1 | 5.5 | 10.0 | 13.6 | 15.6 | 26.0 | 22.5 | 24.1 | 35.3 | 78.7 | 117.0 | 118.2 | |
| Long-term debt | — | — | — | — | 7.3 | 5.6 | 7.5 | 7.3 | 4.3 | — | 9.2 | 9.3 | 6.9 | 9.7 | 5.6 | |
| Short-term debt | — | — | 2.0 | — | — | 1.5 | — | 0.3 | 3.0 | — | — | — | 2.6 | 0.0 | 4.2 | |
| Total liabilities | 0.1 | 0.1 | 4.8 | 5.2 | 12.9 | 16.0 | 21.4 | 23.2 | 36.3 | 27.4 | 36.0 | 51.7 | 346.5 | 564.2 | 539.4 | |
| Shareholders' equity | -0.1 | -0.1 | -3.4 | 82.1 | 56.9 | 79.9 | 161.0 | 218.8 | 610.9 | 506.6 | 420.3 | 397.3 | 413.6 | 174.1 | 48.4 |
USD millions · SEC XBRL
Kura Oncology, Inc. — questions
- How much cash does Kura Oncology, Inc. have?
- $70.2M in cash and cash equivalents as of 2026-06-30.
- How much debt does Kura Oncology, Inc. have?
- $5.6M of long-term debt and $4.2M due within a year as of 2026-06-30.
- What are Kura Oncology, Inc.'s total assets?
- $587.8M as of 2026-06-30.
- What is Kura Oncology, Inc.'s shareholders' equity?
- $48.4M as of 2026-06-30.
Every figure on this page comes from Kura Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.